Enhancing Inclusivity in Clinical Trial Research: Critical Factors in COA Development and Translations

A Pearson Clinical Assessments and Lionbridge Webinar

Learn More About Diversity in Clinical Research and COA Development

Reflections on development and localization of COA content for diverse clinical trial participants.

Join us for a webinar with Pearson Clinical Assessments to explore the role of diversity in endpoint development and generalizable outcomes. Attendees will delve into why including diverse samples in Clinical Outcome Assessments (COAs) development is critical.

We’ll cover the importance of bias reduction in COA Development and review COA translation and adaptation methodology. Join our experts:

J. Lynsey Psimas, Ph.D., Pearson Clinical Assessment’s Director of Business Development
Melinda Johnson, Director of Lionbridge Global COA Operations
Pia Windelov, VP of Lionbridge Life Sciences Strategy and Product Marketing

Wednesday, January 15, 2025
10:00 am ET / 16:00 CET

This session — available in nine languages via AI-generated live captions — is perfect for clinical research and industry professionals, including:

Licensees (Sponsors, CROs)
Key Opinion Leaders
Academics involved in clinical trial research

We’ll leave about 20 minutes for your Q&As on COAs, diversity in clinical research, and Life Sciences language services.

Register Now

Please enter business email.

To find out how we process your personal information, consult our Lionbridge Privacy Policy and Pearson Privacy Policy.

Meet the Moderator and Featured Experts

J. Lynsey Psimas

Ph.D., Director of Business Development, Pearson Clinical Assessments

Dr. Lynsey Psimas is a Licensed Clinical Psychologist with over a decade of industry experience specializing in clinical outcomes assessments and neuropsychological evaluations. In her current role at Pearson Clinical Assessments, she leverages her deep expertise in licensing, COAs, and neurodevelopmental disorders. Dr. Psimas has also worked in academia and private practice, reflecting her diverse skill set and commitment to advancing psychological science.

Melinda Johnson

Director, Global COA Operations, Lionbridge

As Director of Global Clinical Outcome Assessment (COA) Operations, Melinda draws on her linguistic background and deep COA domain expertise. She helps improve patient-centered research and tailors solutions for customers’ needs, including quality, timeliness, and innovation.

Pia Windelov

VP, Life Sciences Strategy and Product Marketing, Lionbridge

Pia has worked for two decades in R&D and across multiple therapeutic areas in pharmaceutical and MedTech industries. She has managed projects within medical device development, Companion Diagnostics, and clinical drug development. Pia was also a key contributor to the Good Lay Summary Practice guidance published on EudraLex, Volume 10, as part of the Clinical Trials guidelines under the EU Clinical Trials Regulation. Educated in linguistics, intercultural communication, and project management, Pia bridges Life Sciences and linguistics to assist customers.

WHAT WE DO

AI

INDUSTRIES